Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

about

Pulmonary hypertension in pregnancy: critical care management Pulmonary arterial hypertension in pregnant women.Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.

P2860

Q36102378-15C1F3E2-D41F-44C7-AC66-3BF97E071EA2 Q38051604-43CFEAFD-D3F4-4A48-8312-B0521B89A999 Q46325726-DAE3B9E4-BB37-43EA-B300-1529FC61D0B2

P2860

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

Item

http://www.wikidata.org/entity/Q42922901

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@en

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@nl

type

Item

label

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@en

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@nl

prefLabel

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@en

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@nl

P1476

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

@en

P2093

C L Campbell

http://www.w3.org/2001/XMLSchema#string

D C Booth

http://www.w3.org/2001/XMLSchema#string

E A Gianferrari

http://www.w3.org/2001/XMLSchema#string

K Y Lain

http://www.w3.org/2001/XMLSchema#string

M J Garabedian

http://www.w3.org/2001/XMLSchema#string

R Y Fragneto

http://www.w3.org/2001/XMLSchema#string

W F Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

Prostaglandin I2 is less relaxant than prostaglandin E2 on the lamb ductus arteriosus.

Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model.

Primary pulmonary hypertension in pregnancy; a role for novel vasodilators.

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

Epoprostenol use in a National Pulmonary Hypertension Centre from 1997 to 2007.

Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy.

P2888

jp.2010.15

P304

628-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JP.2010.15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018247398

http://www.w3.org/2001/XMLSchema#string

P698

20802509

http://www.w3.org/2001/XMLSchema#string

P921

maternal health

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

about

P2860

P2860

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921